Gene and cell therapies, including AAV-mediated gene transfer, gene editing, and LNP-mRNA platforms, are transforming medicine while raising complex questions around developmental and reproductive toxicity (DART) and germline transmission risk assessment. The Developmental and Reproductive Toxicology (DART) and Cell ...
Assessing Developmental, Reproductive and Germline Transmission Risks for Cell and Gene Therapies
September 29, 2026 – September 30, 2026
Washington, DC, and online